!"#$"%&'()*#+,'(-./0(1234()',5(!**+'%( (
|
|
- Marianna Waters
- 8 years ago
- Views:
Transcription
1 THE TUMULTUOUS MARRIAGE OF MORCELLATION AND MIS; CAN OR SHOULD THIS RELATIONSHIP BE SAVED? Julian C. Schink MD Chief of Women s Health Spectrum Health Medical Group Grand Rapids, MI Disclosure! I have no financial conflict of interest.! Every effort is made in this presentation to feature generic products whenever available.! Product names are avoided whenever possible but may slip into images without representing my endorsement of those products! Some products are discussed objectively when no generic equivalent is available, this is not an endorsement of the product.! Only FDA indications for products will be presented. Learning Objectives: 1.! Describe the scientific basis for benign or malignant tumor implantation within the peritoneal cavity. 2.! Characterize the risk of tumor recurrence as well as visceral and vascular injury associated with power morcellation. 3.! Choose alternative strategies to power morcellation which preserve the use of MIS for the management of benign malignant, or undefined neoplasms. 3(
2 History of Power Morcellation! 1995: The FDA approves the first laparoscopic power morcellator with a gynecologic indication for use through its 510(k) process. Since then, the agency has cleared about 2 dozen such devices for use in gynecology.! 2003 Awareness of morcellation misadventures rises.! 2012 Researchers from Brigham and Women s publish report documenting risks of peritoneal spread.! October 2013 Amy Reed MD has surgery at Brigham and Women s with morcellation of occult leiomyosarcoma.! April 17, 2014 (FDA) announcing that it discourages the use of laparoscopic power morcellators in most hysterectomy and myomectomy procedures because of the risk of spreading unsuspected cancerous tissue. Complications associated with Power Morcellation! Mechanical/traumatic injury to:! Bowel! Bladder! Vasculature! Intraperitoneal spread of neoplasm! Benign! leiomyomatosis! dermoids! Tumors of uncertain malignant potential (STUMP)! Endometrial cancer! Uterine sarcoma! Ovarian Cancer! Especially stromal tumors such as granulosa cell Morcellator Misadventures! Reports began in the early 21 st century! Laparoscopic Morcellator-Related Injuries The Journal of the American Association of Gynecologic Laparoscopists, August 2003, Magdy P. Milad, M.D. a,,! eg:laparoscopic morcellator-related complications. J Minim Invasive Gynecol May-Jun;21(3): Milad MP 1, Milad EA 2.! During the past 15 years, 55 complications were identified. Injuries involved the small and large bowels (n = 31), vascular system (n = 27), kidney (n = 3), ureter (n = 3), bladder (n = 1), and diaphragm (n = 1).! What is the true incidence?! Why aren t these reliably captured by the MAUDE database? 1(
3 The sudden increased awareness of disseminating malignancy! Amy Reed, MD, an anesthesiologist at Beth Israel Hospital in Boston, and mother of 6.! Hysterectomy with morcellation. But things didn't go as expected.! Dr. Reed learned a few days after the surgery performed at Brigham and Women s Hospital that she had a uterine leiomyosarcoma and the morcellation may have worsened her prognosis by spreading the cancer around her abdomen. Peritoneal Spread of Neoplasms! From , 1091 instances of uterine morcellation were identified at BWH.! Unexpected diagnoses of leiomyoma variants or atypical and malignant smooth muscle tumors occurred in 1.2% of cases using power morcellation for uterine masses clinically presumed to be fibroids! endometrial stromal sarcoma (ESS), one cellular leiomyoma (CL), six atypical leiomyomas (AL), three smooth muscle tumor of uncertain malignant potential (STUMPs), and one leiomyosarcoma (LMS).! Furthermore, when examining follow-up laparoscopies, both from in-house and consultation cases, disseminated! disease occurred in 64.3% of all tumors Seidman, et al 7(
4 Biologic basis of tumor implantation! Implantation of a tumor graft is based on:! Tumor fragments retain cell-cell interactions and architecture which maintains its microenvironment.! Orthotopic implantation (a site similar in anatomic location) has higher engraftment rate.! Experience from xenograft placement in nude mice finds transplanting 5x5x5 mm tumor to be optimal.! A biologically compatable autograft does not invoke much immune response.! Essential implantation kinases such as VEGF, PDGF, adrenomedulin, and fibroblast growth factor receptor are present in both benign and malignant uterine neoplasms. VEGF function Likelihood of Morcellating an occult cancer! Previous underestimated risk of sarcoma! Was reported as 1;10,000! Parker, etal : Rapidly enlarging fibroids : 1;850! Lack of sensitive or accurate predictive test or clinical circumstance! Other occult malignancies! Endometrial cancer! Ovarian cancer! Neither our eyes nor our imaging accurately predicted the cancer. Are we myopic or just seeing what we hope is there? 8(
5 Frequency of Morcellating Malignancy! Seidman: Seidman et al. PLOS: 1.2% of cases! Peritoneal Dissemination of Morcellation Lesions! The data demonstrate that following power morcellation with an unexpected diagnosis of leiomyoma variant, atypia, or malignancy, exploratory laparoscopy will find evidence of peritoneal dissemination 64.3% of the time.! FDA: 1:352 sarcoma and 1:498 LMS! AAGL abstract: Portland study 4 or 6% cancer morcelated! Ob/Gyn: 2.7% risk of unexpected malignancy in Michigan! If that is not enough, what is the implantation rate of benign neoplams leading to intraperitoneal benign multifocal disease? FDA Guidance! Key points:! Risk 1:352 sarcoma and 1:498 LMS! The FDA is warning against using laparoscopic power morcellators in the majority of women undergoing hysterectomy or myomectomy for uterine fibroids.! If laparoscopic power morcellation is performed in women with unsuspected uterine sarcoma, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis, significantly worsening the patient s longterm survival.! With regard to the spread of unsuspected cancer when using laparoscopic power morcellation for hysterectomy or myomectomy in women with symptomatic uterine fibroids, the FDA considers this to be reportable as a serious injury. Unanticipated Pathology in the Uterine Specimen at the Time of Robotic Sacrocolpopexy M. Pendergrass, B. Osmundsen Journal of Minimally Invasive Gynecology, Vol. 20, Issue 6, S55 Published in issue: November, 2013! Study Objective: To evaluate the prevalence and risk factors of! unanticipated uterine pathology at the time of robotic sacrocolpopexy, Design: This is a cross-sectional prevalence study of women undergoing a hysterectomy at the time of sacrocolpopexy between March 2010 and March 2012.! Patients: 119 women who underwent a hysterectomy Of these, 88 underwent supracervical hysterectomy with morcellation and 31 underwent total hysterectomy.! a mean age of 59, a mean BMI of 27, and an 11% prevalence of diabetes.! The prevalence of unanticipated uterine pathology was 6% (95% CI 2%-11%). Of these seven patients, three had complex endometrial hyperplasia with atypia, and 4 had endometrial cancer.! Conclusion: Our findings bring to light the considerable risk of morcellating unanticipated uterine pathology in a patient without a history abnormal uterine bleeding. 4(
6 Obstetrics and Gynecology: February 2015! Objective:..define incidence of unexpected gynecologic malignacies among women who underwent hysterectomy for benign indications.! Methods: Michigan Surgical Quality Collaborative. 1/1/13-12/8/13. Benign surgical indications. Endometrial and cervical atypia/dysplasia excluded.! 6360 Hyst s for benign indication.! Incidence of unexpected cancer was n=172 = 2.7%! Ovarian cancer, fallopian tube, etc n=69 = 1.08%! Endometrial cancer n=65 = 1.02%! Uterine sarcoma n= 14 = 0.22%! No difference in the mean age, 46.8y vs 47.0 What about benign implants? Obstet Gynecol 2015;125: Professional Organizations Positions! SGO- Fewer than one out of 1000 women who undergo hysterectomy for leiomyomas will have an underlying malignancy!.there is no reliable method to differentiate benign from malignant leiomyomas (leiomyosarcomas or endometrial stromal sarcomas) before they are removed. AAGL-These risks should be weighed in the context of the benefits of a minimally invasive approach as well as the risks and benefits of expectant management or laparotomy.! ACOG- a national prospective morcellation registry is needed. 9(
7 Ethics and Shared Decision Making! FDA: Thoroughly discuss the benefits and risks!be certain to inform the small group of patients for whom laparoscopic power morcellation may be an acceptable therapeutic option that their fibroid(s) may contain unexpected cancerous tissue and that laparoscopic power morcellation may spread the cancer, significantly worsening their prognosis.! What is your obligation?! What is the risk of causing death?! Can you convey this risk clearly? Informed consent: Risks! From AAGL tissue extraction task force! Dissemination of malignant tissue in the peritoneal cavity, which may worsen prognosis.! Dissemination of benign tissue, which may result in untoward health consequences, including the need for re-operation or additional treatments.! Rendering complete pathologic evaluation of a tissue specimen more difficult.! Injury to adjacent organs unique to the technique of morcellation.! These risks should be weighed in the context of the benefits of a minimally invasive approach as well as the risks and benefits of expectant management or laparotomy. Shared Decision Making! What are your responsibilies?! Shared decision making (SDM) is a collaborative process that allows patients and their providers to make health care decisions together, taking into account the best scientific evidence available, as well as the patient's values and preferences.! Patients and clinicians have different expertise when it comes to making consequential clinical decisions. While clinicians know information about the disease, tests and treatments, the patient knows information about their body, their circumstances, their goals for life and healthcare. It is only collaborating on making decisions together that the ideal of evidence-based medicine can come true. This process of sharing in the decision-making tasks involves developing a partnership based on empathy, exchanging information about the available options, deliberating while considering the potential consequences of each one, and making a decision by consensus. :(
8 Bits and Pieces: The Ethics of Uterine Morcellation Arora, Kavita Shah; Spillman, Monique; Milad, Magdy Obstetrics & Gynecology. 124(6): , December 2014!!develop a more robust and nuanced understanding of informed consent for the use of morcellation in benign gynecologic surgery. Ultimately, as physicians, we must remain steadfast in our dedication to the use of evolving technologies to better patient health in a safe and ethical manner that is well-studied, informed, and implemented with appropriate training and precautions. Alternative Strategies! Mechanical (cold knife) morcellation! Vaginal or extracorporeal morcellation! Bag it! Mini-Lap! Versatile access devices Gelpoint Retractor!Alexis retractor!self sealing removable septum!accommodates multiple instruments!incision 1.5 to 7cm ;(
9 Single Incision Total Laparoscopic Hysterectomy Using the GelPOINT Access Platform J.E. Fisher, R.P. Baxix Beumont Health Systems, Royal Oak, Michigan! Total Laparoscopic Hysterectomy with robotic assistance, while technically challenging, is feasible and safe using the Applied Medical GelPOINT Advanced Access Platform. With improved cosmetic results and potential improvement in patient satisfaction, single incision surgery may offer significant advantages over multi-port procedures, while the concurrent use of the robot gives the surgeon the ability to address more complex and difficult pathology than with traditional laparoscopic instrumentation.! November December, 2013 Volume 20, Issue 6! Journal of Minimally Invasive Gynecology GLAD! Versatility of Gelpoint laparoscopy access device (GLAD) as a minimally invasive approach for various gynecologic oncology procedures E. Chapman-Davis, J. Schink, D. Singh, B. Buttin, J.R. Lurain, M.P. Lowe! 29 patients March 2010-March 2011! Mean incision 5.2cm (3-8cm)! Mean tumor size 11.25cm (5-40cm; >10cm 9 patients)! 100% of masses removed without spillage or incision enlargement AAGL guidance regarding bags/pouches Additionally, there are technical challenges associated with the approach:! Variability in size, shape, and weight of uterine tissue makes placing the specimen into the bag challenging.! Puncturing the bag in some cases of multiport laparoscopy can be a risk.! Visualization of the mass within the bag may be suboptimal.! Visualization of vital structures external to the bag may be obscured.! Advanced laparoscopic skills are required to avoid complications performing EMM inside a bag. <(
10 New Strategies! Large bags brought to the incision for essential extracoporeal morcellation or piecemeal extraction! Most commonly using some variation of alexis retractor or similar device.! Prototypical video: Evolving protected morcellation Summary! Intracoporeal Morcellation of the Uterus of Myomas carries with it real risk of disseminating either malignant or benign neoplasm.! These risks were previously under-reported and did not reach public awareness until recently, and then by a victim rather than by our scientific or manufacturing community.! Informed consent and Shared decision making challenge our ability to clearly explain the risk.! Alternatives include: vaginal extraction, mini-lap, abdominal access devices. 32(
11 FDA Statement! UPDATED Laparoscopic Uterine Power Morcellation in Hysterectomy and Myomectomy: FDA Safety Communication The following information updates our April 17, 2014 communication.! Date Issued: Nov. 24, 2014! Based on an FDA analysis of currently available data, we estimate that approximately 1 in 350 women undergoing hysterectomy or myomectomy for the treatment of fibroids is found to have an unsuspected uterine sarcoma, a type of uterine cancer that includes leiomyosarcoma. At this time, there is no reliable method for predicting or testing whether a woman with fibroids may have a uterine sarcoma. FDA continued! If laparoscopic power morcellation is performed in women with unsuspected uterine sarcoma, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis, significantly worsening the patient s long-term survival. While the specific estimate of this risk may not be known with certainty, the FDA believes that the risk is higher than previously understood.! Because of this risk and the availability of alternative surgical options for most women, the FDA is warning against the use of laparoscopic power morcellators in the majority of women undergoing myomectomy or hysterectomy for treatment of fibroids.! Limiting the patients for whom laparoscopic morcellators are indicated, the strong warning on the risk of spreading unsuspected cancer, and the recommendation that doctors share this information directly with their patients, are part of FDA guidance to manufacturers of morcellators. The guidance strongly urges these manufacturers to include this new information in their product labels. FDA guidance! Recommendations for Health Care Providers:! Be aware of the following new contraindications recommended by the FDA;! Laparoscopic power morcellators are contraindicated for removal of uterine tissue containing suspected fibroids in patients who are peri- or post-menopausal, or are candidates for en bloc tissue removal, for example through the vagina or minilaparotomy incision. (Note: These groups of women represent the majority of women with fibroids who undergo hysterectomy and myomectomy.)! Laparoscopic power morcellators are contraindicated in gynecologic surgery in which the tissue to be morcellated is known or suspected to contain malignancy. 33(
Clinical Policy Title: Leiomyosarcoma and Laparoscopic Power Morcellation
Clinical Policy Title: Leiomyosarcoma and Laparoscopic Power Morcellation Clinical Policy Number: 12.03.01 Effective Date: January 1, 2015 Initial Review Date: August 20, 2014 Most Recent Review Date:
More informationHow To Perform Da Vinci Surgery
Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery The Condition: Early Stage Gynecologic Cancer A variety of gynecologic
More informationMorcellation During Uterine Tissue Extraction
Morcellation During Uterine Tissue Extraction AAGL Advancing Minimally Invasive Gynecology Worldwide The Tissue Extraction Task Force members had no commercial, proprietary, or financial interest in the
More informationPhysician. Patient HYSTERECTOMY HYSTERECTOMY. Treatment Options Risks and Benefits Experience and Skill
HYSTERECTOMY Physician Treatment Options Risks and Benefits Experience and Skill Patient Personal Preferences Values and Concerns Lifestyle Choices HYSTERECTOMY Shared Decision Making A process of open
More informationFacing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery
Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery The Condition: Early Stage Gynecologic Cancer A variety of gynecologic
More informationUNITED STATES DISTRICT COURT NORTHERN DISTRICT OF GEORGIA ATLANTA DIVISION
Case 1:15-cv-01046-ODE Document 1 Filed 04/07/15 Page 1 of 66 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF GEORGIA ATLANTA DIVISION EVA C. GALAMBOS and JOHN T. GALAMBOS, v. Plaintiffs, ETHICON, INC.;
More informationConsidering Surgery for Fibroids? Learn about minimally invasive da Vinci Surgery
Considering Surgery for Fibroids? Learn about minimally invasive da Vinci Surgery The Condition: Uterine Fibroid (Fibroid Tumor) A uterine fibroid is a benign (non-cancerous) tumor that grows in the uterine
More informationSumma Health System. A Woman s Guide to Hysterectomy
Summa Health System A Woman s Guide to Hysterectomy Hysterectomy A hysterectomy is a surgical procedure to remove a woman s uterus (womb). The uterus is the organ which shelters and nourishes a baby during
More informationHow To Treat A Uterine Sarcoma
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition 2001 Uterus: Uterine Sarcomas Jeffrey L. Stern, MD Uterine sarcomas
More informationHysterectomy. What is a hysterectomy? Why is hysterectomy done? Are there alternatives to hysterectomy?
ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM What is a hysterectomy? Hysterectomy Hysterectomy is
More informationConsidering a Hysterectomy?
Considering a Hysterectomy? Learn more about virtually scarless surgery using da Vinci Single-Site technology { {Symptoms & Conditions: Chronic Pain, Heavy Bleeding, Fibroids, Endometriosis, Adenomyosis,
More informationFrequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
More informationUnderstanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE
Understanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE Introduction This guide is designed to help you clarify and understand the decisions that need to be made about your care for the
More informationMorcellation During Uterine Tissue Extraction
Morcellation During Uterine Tissue Extraction AAGL Advancing Minimally Invasive Gynecology Worldwide I. Introduction: Minimally Invasive Surgery, Morcellation and the Scope of the Problem The benefits
More informationSurgical Staging of Endometrial Cancer
Surgical Staging of Endometrial Cancer I. Endometrial Cancer Surgical Staging Overview Uterine cancer types: carcinomas type I and type II, sarcomas, carcinosarcomas Hysterectomy with BSO Surgical Staging
More informationMINIMALLY INVASIVE SURGERY FOR WOMEN Back to Life. Faster.
MINIMALLY INVASIVE SURGERY FOR WOMEN Back to Life. Faster. Pictured above: UF gynecologists Sharon Byun, MD, Shireen Madani Sims, MD, and Michael Lukowski, MD, with the robotic surgery equipment. Make
More informationConsidering Endometriosis Surgery? Learn about minimally invasive da Vinci Surgery
Considering Endometriosis Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Endometriosis Endometriosis is a condition in which the tissue that lines your uterus (the endometrium)
More informationHysterectomy. The time to take care of yourself
Hysterectomy The time to take care of yourself The time to take care of yourself Women spend a lot of time taking care of others spouses, children, parents. We often overlook our own needs. But when our
More informationConsidering a Hysterectomy?
Considering a Hysterectomy? Learn more about virtually scarless surgery using da Vinci Single-Site technology { {Symptoms & Conditions: Chronic Pain, Heavy Bleeding, Fibroids, Endometriosis, Pelvic Prolapse
More informationTreating heavy menstrual bleeding caused by fibroids or polyps
Treating heavy menstrual bleeding caused by fibroids or polyps With today s medical advances the outlook for successful treatment of fibroids and polyps has never been better. You don t have to live with
More informationDate: 06/06/2014 Our ref: 4496. I write in response to your request for information in relation to treatment for endometrial cancer in NHS Lothian.
Lothian NHS Board Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG Telephone 0131 536 9000 Fax 0131 536 9088 www.nhslothian.scot.nhs.uk Date: 06/06/2014 Our ref: 4496 Enquiries to: Bryony Pillath Extension:
More informationWomen s Health Laparoscopy Information for patients
Women s Health Laparoscopy Information for patients This leaflet is for women who have been advised to have a laparoscopy. It outlines the common reasons doctors recommend this operation, what will happen
More informationUterine fibroids (Leiomyoma)
Uterine fibroids (Leiomyoma) What are uterine fibroids? Uterine fibroids are fairly common benign (not cancer) growths in the uterus. They occur in about 25 50% of all women. Many women who have fibroids
More informationAbout the Uterus. Hysterectomy may be done to treat conditions that affect the uterus. Some reasons a hysterectomy may be needed include:
Hysterectomy removal of the uterus is a way of treating problems that affect the uterus. Many conditions can be cured with hysterectomy. Because it is major surgery, your doctor may suggest trying other
More informationPower Morcellation and Occult Malignancy in Gynecologic Surgery
Power Morcellation and Occult Malignancy in Gynecologic Surgery!"#$%&'()"*%$+,-G May 2014& Executive Summary!"#$%&'"%($))*+,"-&,-&./-$(")".,(&01%.$%/&2*0&("'$&1-3$%& %$($-+&0(%1+,-/&4$(*10$&"5&("-($%-&*4"1+&+2$&%,06&"5&,-+%*7
More informationNo Costly Hospital Stays. No Unsightly Incisions. Far Faster, Less Painful Recovery.
No Costly Hospital Stays. No Unsightly Incisions. Far Faster, Less Painful Recovery. No Costly Hospital Stays. No Unsightly Incisions. Far Faster, Less Painful Recovery. Welcome to the Georgia Advanced
More informationK Raja/N Varol FPA 2013. FPA Sydney August 31 2013
FPA Sydney August 31 2013 Ms wilson 32 year old woman Presents with worsening, heavy menstrual and intermenstrual bleeding and pain for 6 months. Ms Wilson What is the differential diagnosis What are the
More informationSpecialists In Reproductive Medicine & Surgery, P.A.
Specialists In Reproductive Medicine & Surgery, P.A. Craig R. Sweet, M.D. www.dreamababy.com Fertility@DreamABaby.com Excellence, Experience & Ethics Endometriosis Awareness Week/Month Common Questions
More informationRole of Robotic Surgery in Obese Women with Endometrial Cancer
Role of Robotic Surgery in Obese Women with Endometrial Cancer Anil Tailor Consultant Gynaecological Oncologist Royal Surrey County Hospital Guildford, Surrey, UK St Peters Hospital Chertsey, Surrey, UK
More informationLaparoscopy and Hysteroscopy
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Laparoscopy and Hysteroscopy A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of
More informationA potential treatment for your abnormal uterine bleeding
TRUCLEAR System A potential treatment for your abnormal uterine bleeding Do You Suffer from Abnormal Uterine Bleeding? What is a Hysteroscopy? What is the TRUCLEAR Procedure? What Happens Before Your
More informationLaparoscopic Assisted Vaginal Hysterectomy
Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at ChiaYi 嘉 義 長 庚 紀 念 醫 院 婦 產 科 Clinical Guideline Laparoscopic Assisted Vaginal Hysterectomy By Dr. CJ Tseng Laparoscopic assisted
More informationWOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500. Ovarian Cysts
Ovarian Cysts WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 The ovaries are two small organs located on either side of a woman s uterus. An ovarian cyst is a sac or pouch filled with fluid
More informationUnderstanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS. foundationforwomenscancer.org
Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS foundationforwomenscancer.org Contents Introduction...1 CA 125................................... 1 The CA 125 Test...2 The Use of the CA
More informationHow To Compare The Effects Of A Hysterectomy And A Hysterectomy
A RANDOMIZED TRIAL COMPARING RADICAL HYSTERECTOMY AND PELVIC NODE DISSECTION VS SIMPLE HYSTERECTOMY AND PELVIC NODE DISSECTION IN PATIENTS WITH LOW RISK EARLY STAGE CERVICAL CANCER A Gynecologic Cancer
More informationDA VINCI ROBOTIC HYSTERECTOMY
DA VINCI ROBOTIC HYSTERECTOMY Until recently, surgery for most gynecologic conditions was performed using a large abdominal incision. This is because while conventional laparoscopic surgery is effective
More informationINTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS
INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS Description of Treatment A major difficulty in treating
More informationOvarian Cystectomy / Oophorectomy
Cystectomy and Ovarian Cysts Ovarian cysts are sacs filled with fluids or pockets located on or in an ovary. In some cases, these cysts need to be removed surgically. Types of Cysts Ovarian cysts are quite
More informationFacing Hysterectomy? Learn why da Vinci Surgery may be your best treatment option for early stage gynecologic cancer
Facing Hysterectomy? Learn why da Vinci Surgery may be your best treatment option for early stage gynecologic cancer The Condition: Early Stage Gynecologic Cancer A wide variety of gynecologic cancers
More informationMetastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy
Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy Sarah Hutto,, MSIV Marc Underhill, M.D. January 27, 2009 Past History 45 yo female
More informationTreatment Guide Gynecologic Cancer
Treatment Guide Gynecologic Cancer Cleveland Clinic experts tailor treatment to their patients needs, taking into account the type of cancer, the degree to which the cancer has spread, the age of the individual
More informationThe Role of Laparoscopy in Endometrial Cancer
The Role of Laparoscopy in Endometrial Cancer Prof. Dr. Tugan BEŞE İstanbul University, Cerrahpaşa Medical Faculty Gynecologic Oncology Department Surgical staging in Endometrial Cancer Laparoscopic surgery
More informationCorporate Medical Policy
Corporate Medical Policy Proteomics-based Testing Related to Ovarian Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: proteomics_based_testing_related_to_ovarian_cancer 7/2010
More informationIntroduction Ovarian cysts are a very common female condition. An ovarian cyst is a fluid-filled sac on an ovary in the female reproductive system.
Ovarian Cysts Introduction Ovarian cysts are a very common female condition. An ovarian cyst is a fluid-filled sac on an ovary in the female reproductive system. Most women have ovarian cysts sometime
More informationThe Adnexal Mass and Early Ovarian Cancer
The Adnexal Mass and Early Ovarian Cancer Fred Ueland, MD University of Kentucky Gynecologic Oncology Never give in. Never give in. Never, never, never, never- in nothing great or small, large or petty-
More informationCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future Mazin Al-kasspooles, MD Associate Professor of Surgery Division of Surgical Oncology Director, Regional Therapy
More informationUterine Fibroid Symptoms, Diagnosis and Treatment
Fibroids and IR Uterine Fibroid Symptoms, Diagnosis and Treatment Interventional radiologists use MRIs to determine if fibroids can be embolised, detect alternate causes for the symptoms and rule out misdiagnosis,
More informationGynecology Abnormal Pelvic Anatomy and Physiology: Cervix. Cervix. Nabothian cysts. cervical polyps. leiomyomas. Cervical stenosis
Gynecology Abnormal Pelvic Anatomy and Physiology: (Effective February 2007) pediatric, reproductive, and perimenopausal/postmenopausal (24-28 %) Cervix Nabothian cysts result from chronic cervicitis most
More informationSUBSEROSAL FIBROIDS TREATMENT
INTRODUCTION Uterine fibroids, also known as leiomyomas, are the most common pelvic mass found in women. Fibroids are benign tumors that arise from the uterine muscular tissue (myometrium). They occur
More informationAMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE UTERINE FIBROIDS A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of the Patient
More informationda Vinci Hysterectomy Changing the Experience of Surgery Are you a candidate for a breakthrough approach to hysterectomy?
da Vinci Hysterectomy Changing the Experience of Surgery Are you a candidate for a breakthrough approach to hysterectomy? Your doctor may be able to offer you a new, minimally invasive surgical procedure.
More informationOvarian cancer. A guide for journalists on ovarian cancer and its treatment
Ovarian cancer A guide for journalists on ovarian cancer and its treatment Contents Contents 2 3 Section 1: Ovarian Cancer 4 i. Types of ovarian cancer 4 ii. Causes and risk factors 5 iii. Symptoms and
More informationPRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology
PRODYNOV Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI Image Assisted Laser Therapy for Oncology Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI
More information2/21/2016. Prolapse Surgery after Transvaginal Mesh: The Evolving Landscape. Disclosures. Objectives. No Relevant Disclosures
Prolapse Surgery after Transvaginal Mesh: The Evolving Landscape David R. Ellington, MD, FACOG Assistant Professor Division of Urogynecology and Pelvic Reconstructive Surgery Disclosures No Relevant Disclosures
More informationOvarian Cancer: A Case Report
Ovarian Cancer: A Case Report Abstract Ovarian cancer is a very common cancer among women. It is an extremely diverse disease requiring several treatment options. Occasionally ovarian cancer is diagnosed
More informationFacing Hysterectomy? Learn why da Vinci Surgery may be your best treatment option for a benign gynecologic condition
Facing Hysterectomy? Learn why da Vinci Surgery may be your best treatment option for a benign gynecologic condition The Condition(s): Chronic Pain, Heavy Bleeding, Fibroids, Endometriosis and/or Prolapse
More informationHysterectomy for womb cancer
Gynaecology Oncology Service Hysterectomy for womb cancer April 2014 Great Staff Great Care Great Future INTRODUCTION This leaflet has been produced to provide you with general information about your operation.
More informationWhy would you need a hysterectomy?
Why would you need a hysterectomy? Removal of the uterus is performed to prevent, alleviate, or treat pain, pressure, bleeding, or cancer. Each reason is described in detail in the following pages. Benign
More informationWhy I don t recommend endometrial ablation
Why I don t recommend endometrial ablation Endometrial ablation is a major operative procedure that: o Is ineffective because, according to all research, 40% will ultimately still need a hysterectomy,
More informationThe main surgical options for treating early stage cervical cancer are:
INFORMATION LEAFLET ON TOTAL LAPAROSCOPIC RADICAL HYSTERECTOMY (TLRH) FOR EARLY STAGE CERVICAL CANCER (TREATING EARLY STAGE CERVICAL CANCER BY RADICAL HYSTERECTOMY THROUGH KEYHOLE SURGERY) Aim of the leaflet
More informationA Guide to Hysteroscopy. Patient Education
A Guide to Hysteroscopy Patient Education QUESTIONS AND ANSWERS ABOUT HYSTEROSCOPY Your doctor has recommended that you have a procedure called a hysteroscopy. Naturally, you may have questions about
More informationEndometrial cancer-carcinoma of the lining of the uterus-is the most common gynecologic
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4th Edition 2001 Uterus: Endometrial Carcinoma Jeffrey L. Stern, MD Endometrial
More informationAll you need to know about Endometriosis. Nordica Fertility Centre, Lagos, Asaba, Abuja
All you need to know about Endometriosis October, 2015 About The Author Nordica Lagos Fertility Centre is one of Nigeria's leading centres for world class Assisted Reproductive Services, with comfort centres
More informationOVARIAN CYSTS. Types of Ovarian Cysts There are many types of ovarian cysts and these can be categorized into functional and nonfunctional
OVARIAN CYSTS Follicular Cyst Ovarian cysts are fluid-filled sacs that form within or on the ovary. The majority of these cysts are functional meaning they usually form during a normal menstrual cycle.
More informationKate O Hanlan, M. D. F. A. C. O. G., F. A. C. S.
Kate O Hanlan, M. D. F. A. C. O. G., F. A. C. S. Gynecologic Oncology, Surgery and Endoscopy 4370 Alpine Road Portola Valley, CA 94028-7523 Phone: (650)-851-6669 FAX: (650) 851-9747 Regarding Ovarian Cancer,
More informationGet the Facts, Be Informed, Make YOUR Best Decision. Pelvic Organ Prolapse
Pelvic Organ Prolapse ETHICON Women s Health & Urology, a division of ETHICON, INC., a Johnson & Johnson company, is dedicated to providing innovative solutions for common women s health problems and to
More informationda Vinci Myomectomy Changing the Experience of Surgery Are you a candidate for the latest treatment option for uterine fibroids?
da Vinci Myomectomy Changing the Experience of Surgery Are you a candidate for the latest treatment option for uterine fibroids? Your doctor may be able to offer you a new, minimally invasive surgical
More informationWOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500. Endometriosis
Endometriosis WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 The lining of the uterus is called the endometrium. Sometimes, endometrial tissue grows elsewhere in the body. When this happens
More informationOvarian Cancer. in Georgia, 1999-2003. Georgia Department of Human Resources Division of Public Health
Ovarian Cancer in Georgia, 1999-23 Georgia Department of Human Resources Division of Public Health Acknowledgments Georgia Department of Human Resources......B. J. Walker, Commissioner Division of Public
More informationINTERVENTIONAL PROCEDURES PROGRAMME
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of radical laparoscopic hysterectomy for early stage cervical cancer Introduction This overview
More informationLAPAROSCOPIC OVARIAN CYSTECTOMY
LAPAROSCOPIC OVARIAN CYSTECTOMY Information Leaflet Your Health. Our Priority. Page 2 of 5 About this information This leaflet is for you if you have a cyst on one or both ovaries and are considering surgery.
More informationVaginal Mesh: The FDA Decision and Repurcussions. Roger Dmochowski MD, FACS Dept of Urology Vanderbilt University Medical Center Nashville, TN
Vaginal Mesh: The FDA Decision and Repurcussions Roger Dmochowski MD, FACS Dept of Urology Vanderbilt University Medical Center Nashville, TN 1 ANATOMY FUNCTION 2 Mesh vs No Mesh Outcomes Sivaslioglu 2007
More informationSaint Mary s Hospital. Ovarian Cysts. Information For Patients
Saint Mary s Hospital Ovarian Cysts Information For Patients 2 Contents Welcome 4 What are ovarian cysts? 4 How common are ovarian cysts? 6 Ovarian cysts and fertility 6 What are the symptoms of ovarian
More informationTechnical Update on Tissue Morcellation During Gynaecologic Surgery: Its Uses, Complications, and Risks of Unsuspected Malignancy
SOGC/GOC TECHNICAL UPDATE No. 317, January 2015 Technical Update on Tissue Morcellation During Gynaecologic Surgery: Its Uses, Complications, and Risks of Unsuspected Malignancy This technical update has
More informationLaparoscopic Hysterectomy
Any further questions? Please contact the matron for Women s Health on 020 7288 5161 (answerphone) Monday - Thursday 9am - 5pm. For more information: Royal College of Obstetrics and Gynaecology Recovering
More informationUterus myomatosus. 10-May-15. Clinical presentation. Incidence. Causes? 3 out of 4 women. Growth rate vary. Most common solid pelvic tumor in women
Uterus myomatosus A.J. Henriquez March 14, 2015 Uterus myomatosus Definition, incidence, clinical presentation and diagnosis. New FIGO classification for uterine leiomyomas Brief description on treatment
More informationThe percentage of women 21-64 years of age who received one or more Pap tests to screen for cervical cancer.
Measure Name: Cervical Cancer Screen Owner: NCQA (CCS) Measure Code: CER Lab Data: Y Rule Description: General Criteria Summary The percentage of women 21-64 years of age who received one or more Pap tests
More informationOvarian cysts Diagnosis and Management
Ovarian cysts Diagnosis and Management Mr P K Athanasias MRCOG Consultant Gynaecologist St Anthony s Hospital pathanasias@gmail.com Introduction ovary is an ovum-producing reproductive organ located in
More informationSouth Dakota Task Force to Study Abortion Pierre, South Dakota September 21, 2005
South Dakota Task Force to Study Abortion Pierre, South Dakota September 21, 2005 Section III. : The review and exposition of the body of medical, psychological, and sociological knowledge that has accumulated
More informationFertility Preservation in Women with Cancer. Objectives. Patient #1 10/24/2011. The audience will understand: How cancer therapy affects fertility.
Fertility Preservation in Women with Cancer Leslie R. DeMars Dartmouth-Hitchcock Medical Center Objectives The audience will understand: How cancer therapy affects fertility. Who should be considered for
More informationThe following chapter is called The Role of Endoscopy, Laparoscopy, and Hysteroscopy in Infertility.
Welcome to Chapter 14. The following chapter is called The Role of Endoscopy, Laparoscopy, and Hysteroscopy in Infertility. The authors are Dr. Jose Remohi and Dr. Jaime Ferro. 1 There are several tools
More informationBard: Continence Therapy. Stress Urinary Incontinence. Regaining Control. Restoring Your Lifestyle.
Bard: Continence Therapy Stress Urinary Incontinence Regaining Control. Restoring Your Lifestyle. Stress Urinary Incontinence Becoming knowledgeable about urinary incontinence Uterus Normal Pelvic Anatomy
More informationCarcinoma of the vagina is a relatively uncommon disease, affecting only about 2,000 women in
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition, 2001 Vagina Jeffrey L. Stern, MD Carcinoma of the vagina is
More informationPOSTMENOPAUSAL ASSESS AND WHAT TO DO
POSTMENOPAUSAL OVARIAN CYSTS:HOW TO ASSESS AND WHAT TO DO Steven R. Goldstein, MD Professor of Obstetrics and Gynecology Director of Gynecologic Ultrasound Co-Director, Bone Densitometry New York University
More informationThe Centre For Women s Reproductive Care HYSTERECTOMY
The Centre For Women s Reproductive Care Baringa Private Hospital, 31 Mackays Rd Coffs Harbour NSW 2450 Harvey Ward MB ChB, BSc(Med), FCOG (SA), MMed (O&G), FRANZCOG Obstetrician & Gynaecologist Phone:
More informationGYNECOLOGIC CANCERS Facts to Help Patients Make an Informed Decision
RADIATION THERAPY FOR GYNECOLOGIC CANCERS Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY FACTS ABOUT GYNECOLOGIC CANCERS Gynecologic cancers
More informationPOST MENOPAUSAL BLEEDING CHECKLIST. Ultrasound. Information folder given to patient. Booking form faxed/emailed
POST MENOPAUSAL BLEEDING CHECKLIST Ultrasound Information folder given to patient Booking form faxed/emailed 1 BOOKING FORM - HYSTEROSCOPY FOR POST MENOPAUSAL BLEEDING Patient s Name: Surname: DOB: / /
More informationPatient. Frequently Asked Questions. Transvaginal Surgical Mesh for Pelvic Organ Prolapse
Patient Frequently Asked Questions Transvaginal Surgical Mesh for Pelvic Organ Prolapse Frequently Asked Questions WHAT IS PELVIC ORGAN PROLAPSE AND HOW IS IT TREATED? Q: What is pelvic organ prolapse
More informationCoding for multiple surgical procedures By Emily H. Hill, PA
Coding for multiple surgical procedures By Emily H. Hill, PA Many times, more than one surgical procedure is performed during the same encounter. When that occurs, a modifier(s) is required to explain
More informationOVARIAN CANCER IS A MAJOR CAUSE OF MORBIDITY AND MORTALITY IN WOMEN. Name of Student HTHSCI 1110 WEBER STATE UNIVERSITY.
Ovarian Cancer 2 OVARIAN CANCER IS A MAJOR CAUSE OF MORBIDITY AND MORTALITY IN WOMEN by Name of Student HTHSCI 1110 WEBER STATE UNIVERSITY Ogden, Utah Instructor s Name Date Ovarian Cancer 2 Background
More informationUNC FIBROID CARE CLINIC. Department of Obstetrics and Gynecology Division of Advanced Laparoscopy & Pelvic Pain
The purpose of the Fibroid Care Clinic at the University of North Carolina is to provide up-to-date, comprehensive medical information and care for the treatment of women with uterine fibroids. We offer
More informationWelcome to Cartersville Ob/Gyn Associates.
Welcome to Cartersville Ob/Gyn Associates. We are a full-service Ob/Gyn practice, delivering women the exceptional care, medical expertise, compassion and support they deserve through every life cycle
More informationNovaSure: A Procedure for Heavy Menstrual Bleeding
NovaSure: A Procedure for Heavy Menstrual Bleeding The one-time, five-minute procedure Over a million women 1 have been treated with NovaSure. NovaSure Endometrial Ablation (EA) is the simple, one-time,
More informationOvarian Cancer. Understanding your diagnosis
Ovarian Cancer Understanding your diagnosis Ovarian Cancer Understanding your diagnosis When you first hear that you have cancer, you may feel alone and afraid. You may be overwhelmed by the large amount
More informationContributors Marjan Attaran, MD Mohamed A. Bedaiwy, MD, PhD Andrew Brill, MD Chi Chiung Grace Chen, MD Gouri B. Diwadkar, MD Richard D.
Contributors Marjan Attaran, MD Transposition Mohamed A. Bedaiwy, MD, PhD Associate Professor, Department of Obstetrics and Gynecology, Assiut School of Medicine, Assiut, Egypt, Clinical Fellow, Department
More informationda Vinci and Beyond Simon DiMaio, Ph.D. Intuitive Surgical 21 July 2014
da Vinci and Beyond Simon DiMaio, Ph.D. Intuitive Surgical 21 July 2014 Medical Robots as Products Radio- Therapy Robots Robotic Assistants Tele- Robots MEDICAL ROBOTICS Imaging Robots Image- Guided Robots
More informationWhat are the differences between fibroid and ovarian cyst?
DR LEE KEEN WHYE MBBS (Singapore), FRCOG (U.K), FAMS (Singapore) Consultant Obstetrician & Gynaecologist Advisor, Endometriosis Association, Singapore KW Lee Clinic & Surgery For Women No. 6 Napier Road,
More informationPolyps. Hyperplasias. CAP 2011: Course AP104. The High Risk Benign Endometrium. Mutter and Nucci 1
Course AP104 Endometrial Hyperplasia A morphologic Definition Hyperplasias Hormonal Effect or Precancer? George L. Mutter, MD Harvard Medical School and Brigham and Women s Hospital Boston, MA Endometrial
More informationFacing Pancreatic Surgery? Learn about minimally invasive da Vinci Surgery
Facing Pancreatic Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Pancreatitis/Pancreatic Cancer The pancreas is an organ that produces enzymes and hormones to help your body digest
More information2016 Hysterectomy Reimbursement Fact Sheet
2016 Hysterectomy Reimbursement Fact Sheet The information contained in this document is provided for informational purposes only and represents no statement, promise, or guarantee by Ethicon concerning
More information